As illustrated in Scheme 1, these nanomotors, formed via self-assembly of iron carbonyl (FeCO)-bridged silane monomers and the TLR7 agonist resiquimod (R848), enable precise targeting of cancer cells under X-ray irradiation, facilitating efficient cargo delivery, tumor cell elimination, and immune activation. The gene discussed is TLR7; the disease is neoplasm.